ClinicalTrials.gg
Not yet recruitingNCT06573047Updated Feb 13, 2025

Thoracic KT on Pulmonary Function Ichildren with Pneumonia

An interventional study of kinesotape and Chest physiotherapy exercises in Pneumonia Childhood, sponsored by Cairo University. Not yet recruiting. Open to participants aged 4 Years to 7 Years. Per ClinicalTrials.gov, last updated 2025-02-13.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
4 Years to 7 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Pneumonia by Cairo University — 4 open to participants now, 4 under way, none of them phase 3. Pneumonia · Cairo University.

Planned enrollment
10th of 11
40 · median 60
Started
2025
with 2 others
No phase
9 of 13
3 open now
Registered
11th of 13
by date

Among the 13 studies in Pneumonia by Cairo University, this one is the 10th largest by planned enrollment of the 11 interventional ones that give a count, is one of 3 that started in 2025, is one of 9 with no phase, and was the 11th registered.

Pneumonia

1,569 studies on the registry are indexed under Pneumonia; 267 are open to participants now.

Browse Pneumonia studies →

Open to participants now

4 of the 13 studies in Pneumonia by Cairo University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 159 Pneumonia studies recruiting now, 84 (53%) set no upper age limit and 48 (30%) stop at 75 or younger; 40 take children under 18; 23 take healthy volunteers.

This study: 4 Years to 7 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Pneumonia by Cairo University, or all of them as a file.
02

Study summary

This study aimed to investigate the effect of thoracic kinesio-tape on Pulmonary Functions, time to clinical resolution and respiratory rate and arterial oxygen saturation in children with pneumonia.

Thirty children with pneumonia from both sexes with age ranged from 4 to 7 years participated in this study. The patients were divided into two equal groups (study and control groups), control group received selected chest physiotherapy exercise. Study group received the same selected physical therapy program given to control group in addition to thoracic kinesio-tape three days per week for two weeks.

Read the detailed description

The study targeted the children with pneumonia (4-7) from both sexes will be selected from tala general hospital in menofia Study design: Randomized controlled trial.

Inclusion Criteria:

1- Children with age between aged 4years to 7 years hospitalized with pneumonia and they assemble all the clinical and radiological criteria for pneumonia 2- Children with stable hemodynamic status 3- Children with no previous history of thoracic surgery, thoracic deformities rib fracture or any condition that make it difficult to apply the KT.

Exclusion criteria:

  1. Children with chest drain
  2. Children with vision or auditory problems
  3. Bone fragility or rib fractures
  4. Children with reports of allergic skin reactions to the use of adhesive bandages, plasters, or other adhesive materials
  5. Children on ventilator
  6. cp children

    I. For Children Selection

    • X-ray to detect the presence of lung infiltrates indicated

    II. For Children Evulation a- Digital spirometer: used to measure pulmonary function include (vital capcity -forced vital capcity -forced expiratory volume1-forced expiratory volume1/forced vital capcity ratio-peak expiratory flow) at the start and at the end of the study.

    B- A pulse oximeter : used to measure oxygen saturation. It is a non-invasive device placed over a person's finger.

    C - The Clinical Respiratory Score (CRS) : The Clinical Respiratory Score appears to have potential as a screening tool for respiratory distress presentations (of several etiologies) in the paediatric emergency department setting of a Low and Middle -Income Countries .Respiratory Score assessed respiratory status in children hospital.

    For treatment

    a- Kinesio-tape made from 100% gentle cotton fibre and 100% medical grade acrylic adhesive. its Hypoallergenic, water-resistant and does not limit range of motion (ROM). Kinesio Tape is safe enough for a baby's sensitive skin, and gentle enough for aging individuals, flexible enough for rehabilitation, durable enough to support working muscle, joint or ligament and strong enough for athletes at any level.

    c- Procedures I. For Children Selection

    • All chest radiographs will be interpreted in the department of radiology (A/P view) and reviewed by pediatric chest physician
    • Children will be clinically evaluated at enrolment of the study and at discharge. A standardized protocol will be taken to record respiratory rate, arterial oxygen saturation.

    II. For Children Evaluation: all children will be evaluated before and after intervention and after 2 weeks from intervention by

1- Pulmonary functions testing: To perform the measurement, subjects will be instructed to sit on an armless chair with back support while their knees flexed to 90° and nostrils will be occluded by a nose clip. Then they will perform a maximal inspiration followed by a forced expiration, exhaling as much air as possible 3 seconds. This maneuver will be repeated 3 times, and the highest scores will be recorded for analyses.

2- Time to clinical resolution which will be defined as the number of days needed for a patient to achieve the following clinical parameters: afebrile (daily maximum body temperature:37.5°C, oxygen saturation :95% and absence of severe signs 3- Respiratory rate and arterial oxygen saturation. A standardized protocol will be taken to record respiratory rate, arterial oxygen saturation. The standard technique for measurement of respiratory rate and arterial oxygen saturation will be the same as previously reported. The daily maximum body temperature was noted by the pediatrician based on the patient's nursing record. The patient's axillary temperature was measured by the attending nurses every 3 hours throughout the hospital stay. All physicians and nurses will be blinded to group assignment and study protocol.

4-The Clinical Respiratory Score (CRS) : The four clinical parameters were : respiratory rate , retractions ,dyspnea and auscultation (table 1) . the score ranged from 1-12 with a higher score indicating more respiratory distress .The score was designed for use while child was awake. the total score obtained there can be 3 categories of respiratory distress: Mild (1- 3), Moderate (4-7), Severe (8-12)

III. Procedures for treatment The control group : the children in the control group will receive the selected chest physiotherapy exercise three times per week for two weeks, each session will be about 20 minutes which included the following exercise;

  1. Postural drainage : which involves positioning of the child with the assistance of gravity to mobilize secretions towards the main bronchus .
  2. Vibration: In this technique, a rapid vibratory impulse is transmitted through the chest wall from the flattened hands of the therapist by isometric alternate contraction of forearm flexor and extensor muscles, to loosen and dislodge the airway secretions .
  3. Percussion: The therapist uses a single hand or both cupped hands or three fingers with the middle finger tented, or a facemask with the port either covered or occluded by a finger, and strikes repeatedly at a rate of three per second over the part of the bronchopulmonary segment that needs to be drained.
  4. Huffing: Fast expiration at high volume by the patient .
  5. Coughing: Child is requested to cough. In uncooperative or small children, tracheal stimulation or tickling can be performed by placing index finger or thumb on the anterior side of the neck against trachea just above sternal notch with gentle but firm inward pressure in a circular pattern as the child begins to exhale • Thoracic squeezing. This method stimulates the normal cough mechanism through elevation of intrathoracic pressure. This technique, which does not require any special equipment, is used exclusively for the thorax. The hands are placed on the lower third of the thorax. The therapist then applies pressure to increase the forced expiratory volume (FEV) by 30%. It is not necessary to disconnect the patient from the ventilation machine during treatment, which decreases episodes of hypoxemia and the use of high fraction of inspired oxygen (FiO2)

The control Group (B): will receive selected chest physical therapy exercise three times per week for two weeks, each session will be about 20 minutes plus thoracic kinesio-tape every three days (5 times per two weeks). Children will be seated on a chair. When the children will be at the end of the expiration, it will be applied bilaterally on the fifth to sixth and ninth to tenth intercostal muscles transversally and on the anterior and posterior axillary line longitudinally with 50% tension. To stimulate the muscle and support the function, the stimulation technique is usually applied from the origin to the insertion of the muscle with the recommended stretching of 25 to 50%. KT is changed on every third day (for a total of 5 times per two weeks). The children or the care giver will be instructed not to take the tapes off at any time but they will be allowed to take showers. The researcher will complete post treatment evaluations after two weeks for each patient and recorded the data.

03

Conditions studied

  • Pneumonia Childhood

Browse trials for

04

Who can participate

Ages eligible
4 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children with age between aged 4 years to 7 years hospitalized with pneumonia and they assemble all the clinical and radiological criteria for pneumonia
  2. Children with normal thoracic spine
  3. Children with stable hemodynamic status
  4. Children with no previous history of thoracic surgery, thoracic deformities rib fracture or any condition that make it difficult to apply the KT.

Exclusion criteria

Exclusion Criteria:

  1. Children with chest drain
  2. Children with vision or auditory problems
  3. Bone fragility or rib fractures
  4. Children with reports of allergic skin reactions to the use of adhesive bandages, plasters, or other adhesive materials
  5. Children on ventilator
  6. cp children
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Other
    Kinesotape

    Children in group (b)will receive selected chest physical therapy exercise which including (percussion, huffing, coughing and postural drainage)three times per week for two weeks, each session will be about 20 minutesplus thoracic kinesio-tape every three days (5 times per two weeks). Children will be seated on a chair. When the children will be at the end of the expiration, it will be applied bilaterally on the fifth to sixth and ninth to tenth intercostal muscles transversally and on the anterior and posterior axillary line longitudinally with 50% tension

    Other: kinesotape

  • Other
    chest physiotherapy exercises

    the children in the group(a) will receive the selected chest physiotherapy exercise three times per week for two weeks, each session will be about 20 minute which will include the following exercise ( huffing , coughing , percussion,and postural drainage)

    Behavioral: Chest physiotherapy exercises

Interventions

  • Otherkinesotape

    a- Kinesio-tape: cure tape (made in Korea) made from 100% gentle cotton fibre and 100% medical grade acrylic adhesive. its Hypoallergenic, water-resistant and does not limit range of motion (ROM), it is come with different colours and sizes. Kinesio Tape is safe enough for a baby's sensitive skin, and gentle enough for aging individuals, flexible enough for rehabilitation, durable enough to support working muscle, joint or ligament and strong enough for athletes at any level.

  • BehavioralChest physiotherapy exercises

    selected chest physiotherapy exercise three times per week for two weeks, each session will be about 20 minute which will include the following exercise ( huffing , coughing , percussion,and postural drainage)

06

What researchers measure

Primary outcomes

  1. pulmonary function

    Vital capacity will carried out by using digital spirometer

    Time frame: baseline- 5min for each participant

  2. Forced vital capacity

    By using digital spirometer

    Time frame: baseline- 5min for each participant

  3. Forced expiratory volume in one second

    By using digital spirometer

    Time frame: baseline- 5min for each participant

  4. Forced vital capacity/forced expiratory volume in one second ratio

    By using digital spirometer

    Time frame: baseline- 5min for each participant

  5. Peak expiratory flow

    By using digital spirometer

    Time frame: baseline- 5min for each participant

  6. Oxygen saturation

    By using oximeter

    Time frame: baseline- 5min for each participant

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2025; primary completion for Jun 2025, 1 month later.

Of 260 non-industry interventional studies with no phase under Pneumonia, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 31. This study's planned 1 month is below that.

Counting every sponsor, half of 267 studies reached it within 22 months; a quarter within 11 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2024
First posted
Aug 27, 2024
StartEst.
May 2025
Primary completionEst.
Jun 2025
CompletionEst.
Jul 2025
Last update
Feb 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06573047
Lead sponsor
Cairo University
Responsible party
Sara Ali taher elhanfi (Physiotherapist, Cairo University) — Principal investigator
First posted
Aug 27, 2024
Start date
May 2025 (estimated)
Primary completion
Jun 2025 (estimated)
Completion
Jul 2025 (estimated)
Last update
Feb 13, 2025

Study contacts

Sara elhanfi
Contact
selhanfi54@gmail.com
+2001221625794
Mohamed Elshafeay
Contact
+2001067179565
Sara Elhanfi
principal investigator · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion